REGISTERED NUMBER: 07494347 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

WALSALL ROAD MEDICAL LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr S Bath

Dr S Deller

Dr G Hundle

Dr M Latthe

Dr T Soyannwo

Dr S Bath

REGISTERED OFFICE:

Rex Buildings

Alderley Road

Wilmslow

Cheshire

SK9 1HY

REGISTERED NUMBER:

07494347 (England and Wales)

FIXED ASSETS

Tangible assets

4

4,590

11,857

Investment property

5

7,050,000

7,825,000

7,054,590

7,836,857

CURRENT ASSETS

Debtors

6

107,229

163,469

Cash at bank

206,047

224,384

313,276

387,853

CREDITORS

Amounts falling due within one year

7

463,085

636,416

NET CURRENT LIABILITIES

(149,809

)

(248,563

)

TOTAL ASSETS LESS CURRENT LIABILITIES

6,904,781

7,588,294

CREDITORS

Amounts falling due after more than one year

8

(4,230,328

)

(4,165,648

)

PROVISIONS FOR LIABILITIES

9

(191,973

)

(185,498

)

NET ASSETS

2,482,480

3,237,148

CAPITAL AND RESERVES

Called up share capital

10

10

10

Revaluation reserve

11

859,955

1,634,955

Retained earnings

1,622,515

1,602,183

SHAREHOLDERS' FUNDS

2,482,480

3,237,148

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 September 2025 and were signed on its behalf by:

Dr T Soyannwo - Director

1.	STATUTORY INFORMATION

Walsall Road Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

RELATED PARTY EXEMPTION

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

TURNOVER

The turnover shown in the profit and loss account represents amount earned during the year and is recognised when the company obtains the right to consideration.

TANGIBLE FIXED ASSETS

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Fixtures and fittings

-

10% on cost

All fixed assets are initially recorded at cost.

INVESTMENT PROPERTY

Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 6 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

fittings

£

COST

At 1 April 2024

and 31 March 2025

80,176

DEPRECIATION

At 1 April 2024

68,319

Charge for year

7,267

At 31 March 2025

75,586

NET BOOK VALUE

At 31 March 2025

4,590

At 31 March 2024

11,857

5.	INVESTMENT PROPERTY

Total

£

FAIR VALUE

At 1 April 2024

7,825,000

Revaluations

(775,000

)

At 31 March 2025

7,050,000

NET BOOK VALUE

At 31 March 2025

7,050,000

At 31 March 2024

7,825,000

Fair value at 31 March 2025 is represented by:

£

Valuation in 2025

7,050,000

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

93,646

106,386

Tower Hill intercompany

13,583

57,083

107,229

163,469

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

113,880

211,760

Trade creditors

341,628

401,537

Tax

7,577

23,119

463,085

636,416

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank loans - 1-2 years

113,880

211,760

Bank loans - 2-5 years

341,640

635,280

Bank loans > 5 years

3,774,808

3,318,608

4,230,328

4,165,648

Amounts falling due in more than five years:

Repayable by instalments

Bank loans > 5 years

3,774,808

3,318,608

9.	PROVISIONS FOR LIABILITIES

2025

2024

£

£

Deferred tax

191,973

185,498

Deferred

tax

£

Balance at 1 April 2024

185,498

Charge to Income Statement during year

6,475

Balance at 31 March 2025

191,973

10.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

10

Ordinary

£1

10

10

11.

RESERVES

Revaluation

reserve

£

At 1 April 2024

1,634,955

Transfer to retained earnings

(775,000

)

At 31 March 2025

859,955